NEXTPOINT
LIVE

Serial Number

99075283

Owner

NextPoint Therapeutics, Inc.

Attorney

Chang Hong

Filing Date

Mar 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NEXTPOINT Trademark

Serial Number: 99075283

NEXTPOINT is a trademark filed by NextPoint Therapeutics, Inc. on March 10, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

NextPoint Therapeutics, Inc. (3 trademarks)

238 Main Street
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

March 10, 2025

Registration Date

Not Registered

Published for Opposition

September 16, 2025

Goods & Services

Pharmaceutical products for the treatment of cancer; Antibodies for medical purposes

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use

Pharmaceutical products development; Pharmaceutical research and development; Research and development of medicines; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immunotherapy and immuno-oncology; Research and development in the field of immunotherapy and immuno-oncology

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 15, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 15, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 15, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 15, 2025 CNEA
ASSIGNED TO EXAMINER
Aug 11, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 29, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 10, 2025 MAFR
NEW APPLICATION ENTERED
Mar 10, 2025 NWAP